Hydroxychloroquine versus Azithromycin for Hospitalized Patients with COVID-19. Results of a Randomized, Active Comparator Trial

Rationale: The coronavirus disease (COVID-19) pandemic struck an immunologically naive, globally interconnected population. In the face of a new infectious agent causing acute respiratory failure for which there were no known effective therapies, rapid, often pragmatic trials were necessary to evalu...

Full beskrivning

Sparad:
Bibliografiska uppgifter
I publikationen:Ann Am Thorac Soc
Huvudupphovsmän: Brown, Samuel M., Peltan, Ithan, Kumar, Naresh, Leither, Lindsay, Webb, Brandon J., Starr, Nathan, Grissom, Colin K., Buckel, Whitney R., Srivastava, Rajendu, Butler, Allison M., Groat, Danielle, Haaland, Benjamin, Ying, Jian, Harris, Estelle, Johnson, Stacy, Paine, Robert, Greene, Tom
Materialtyp: Artigo
Språk:Inglês
Publicerad: American Thoracic Society 2021
Ämnen:
Original Research
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC8009003/
https://ncbi.nlm.nih.gov/pubmed/33166179
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1513/AnnalsATS.202008-940OC
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk